Join
Live feed
·
INSIDERFilingvia Quantisnow
Jazz Pharmaceuticals plc logo

EVP, Global Head of R&D & CMO Iannone Robert covered exercise/tax liability with 6,209 units of Ordinary Shares, decreasing direct ownership by 7% to 88,871 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
JAZZ· Jazz Pharmaceuticals plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JAZZ (Jazz Pharmaceuticals plc) and more on Quantisnow.